498 related articles for article (PubMed ID: 24304502)
1. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
3. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
4. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation.
Singh P; Barpande SR; Bhavthankar JD; Mandale MS; Bhagwat AU
Indian J Dent Res; 2017; 28(2):162-168. PubMed ID: 28611326
[TBL] [Abstract][Full Text] [Related]
5. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
6. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
7. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
8. Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
Hsu YP; Hsieh CH; Chien HT; Lai CH; Tsao CK; Liao CT; Kang CJ; Wang HM; Chang JT; Huang SF
World J Surg Oncol; 2015 Aug; 13():253. PubMed ID: 26292957
[TBL] [Abstract][Full Text] [Related]
9. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
Feng XY; Li JH; Li JZ; Han ZX; Xing RD
Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-based immunosensor using three-dimensional CNT network structure for sensitive and reproducible detection of oral squamous cell carcinoma biomarker.
Song CK; Oh E; Kang MS; Shin BS; Han SY; Jung M; Lee ES; Yoon SY; Sung MM; Ng WB; Cho NJ; Lee H
Anal Chim Acta; 2018 Oct; 1027():101-108. PubMed ID: 29866259
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
12. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA; Shaker OG
Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
[TBL] [Abstract][Full Text] [Related]
13. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
14. Salivary microRNAs in oral cancer.
Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
[TBL] [Abstract][Full Text] [Related]
15. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
16. Concomitant analysis of salivary tumor markers--a new diagnostic tool for oral cancer.
Nagler R; Bahar G; Shpitzer T; Feinmesser R
Clin Cancer Res; 2006 Jul; 12(13):3979-84. PubMed ID: 16818695
[TBL] [Abstract][Full Text] [Related]
17. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity.
Rajkumar K; Nandhini G; Ramya R; Rajashree P; Kumar AR; Anandan SN
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):309-19. PubMed ID: 24950604
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: a systematic review.
Gualtero DF; Suarez Castillo A
Acta Odontol Scand; 2016; 74(3):170-7. PubMed ID: 26577643
[TBL] [Abstract][Full Text] [Related]
19. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
20. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
Metgud R; Bajaj S
Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]